39 /100
MEDIUM RISK
Score updated Jul 14, 2026

CGCT — Cartesian Growth Corporation III Dilution Risk Tracker

Track CGCT dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track CGCT — Get alerts when the score changes →

As of July 14, 2026, Cartesian Growth Corporation III (CGCT) has a DilutionWatch DilutionScore of 39/100, rated MEDIUM dilution risk. Cartesian Growth Corporation III has a market capitalization of $518.74M, 5.07M shares outstanding, 64 institutional holders tracked.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
40
📊 Float Risk
7
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for CGCT.
🔔 Track CGCT — Get forecast alerts →

💹 Market Data

Market Cap$518.74M
Shares Outstanding5.07M
FloatN/A
CashN/A
DebtN/A
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 1.9% shares (2026Q1 vs prior)
64 institutional holders · 28.73M shares
#1 Fort Baker Capital Management LP 2.70M shares
#2 HIGHBRIDGE CAPITAL MANAGEMENT LLC 2.02M shares
#3 JPMORGAN CHASE & CO 2.02M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest22.8K
Days to Cover1.0
% of FloatN/A
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Mar 31, 2026
xbrl XBRL CONVERTIBLE Mar 31, 2026
4 INSIDER TRANSACTION Apr 02, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for CGCT Shareholders

Cartesian Growth Corporation III (CGCT) has a DilutionScore of 39/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 14, 2026.

DilutionWatch's EDGAR monitoring for CGCT shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for CGCT in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for CGCT alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track CGCT Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking CGCT — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for CGCT
📊 CGCT FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 CGCT Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.